The renal hemodynamic basis of diabetic nephropathy - PubMed (original) (raw)
Affiliations
- PMID: 9148381
Review
The renal hemodynamic basis of diabetic nephropathy
G T O'Bryan et al. Semin Nephrol. 1997 Mar.
Abstract
Diabetic nephropathy occurs in approximately one third of individuals with insulin-dependent diabetes mellitus (IDDM), recent studies suggest that a similar proportion of non-insulin-dependent diabetes mellitus (NIDDM) patients develop this serious complication as well. Of the many risk factors identified in the pathogenesis of nephropathy, hemodynamic alterations have been particularly well studied. Increases in glomerular filtration rate (GFR), largely driven by increases in plasma flow and glomerular capillary pressure, are apparent in early IDDM and NIDDM. Furthermore, the elevation in capillary pressure may be damaging to glomerular endothelial, epithelial and mesangial cells, thereby initiating and contributing to the progression of diabetic nephropathy. Numerous mediators of diabetic hyperfiltration have been proposed, and this phenomenon likely reflects a mutilfactorial etiology. The purpose of this article is to examine the hemodynamic alterations characteristic of diabetic nephropathy, their etiology, and their role in the development and progression of diabetic nephropathy.
Similar articles
- Renal functional reserve in subjects with diabetes mellitus.
Jones SL, Viberti G. Jones SL, et al. Semin Nephrol. 1995 Sep;15(5):475-81. Semin Nephrol. 1995. PMID: 8525151 Review. - [Arterial hypertension and diabetic nephropathy].
Chaignon M, Guedon J. Chaignon M, et al. J Mal Vasc. 1992;17(4):311-4. J Mal Vasc. 1992. PMID: 1494060 Review. French. - Role of mesangial expansion in the pathogenesis of diabetic nephropathy.
Dalla Vestra M, Saller A, Mauer M, Fioretto P. Dalla Vestra M, et al. J Nephrol. 2001 Nov-Dec;14 Suppl 4:S51-7. J Nephrol. 2001. PMID: 11798146 Review. - [Progressive course of nephropathy with non-insulin-dependent diabetes mellitus--structural-functional relationship].
Ishihara K, Kanauchi M, Dohi K, Ishikawa H. Ishihara K, et al. Nihon Jinzo Gakkai Shi. 1993 Jun;35(6):715-22. Nihon Jinzo Gakkai Shi. 1993. PMID: 8377284 Japanese. - Hypertension and diabetic renal disease.
Fioretto P, Steffes MW, Mauer SM. Fioretto P, et al. Clin Invest Med. 1991 Dec;14(6):630-5. Clin Invest Med. 1991. PMID: 1794213 Review.
Cited by
- FOG2 protein down-regulation by transforming growth factor-β1-induced microRNA-200b/c leads to Akt kinase activation and glomerular mesangial hypertrophy related to diabetic nephropathy.
Park JT, Kato M, Yuan H, Castro N, Lanting L, Wang M, Natarajan R. Park JT, et al. J Biol Chem. 2013 Aug 2;288(31):22469-80. doi: 10.1074/jbc.M113.453043. Epub 2013 Jun 20. J Biol Chem. 2013. PMID: 23788640 Free PMC article. - Altered renal sodium transporter expression in an animal model of type 2 diabetes mellitus.
Oh YK, Joo KW, Lee JW, Jeon US, Lim CS, Han JS, Knepper MA, Na KY. Oh YK, et al. J Korean Med Sci. 2007 Dec;22(6):1034-41. doi: 10.3346/jkms.2007.22.6.1034. J Korean Med Sci. 2007. PMID: 18162719 Free PMC article. - SGLT2 inhibition and kidney protection.
Nespoux J, Vallon V. Nespoux J, et al. Clin Sci (Lond). 2018 Jun 28;132(12):1329-1339. doi: 10.1042/CS20171298. Print 2018 Jun 29. Clin Sci (Lond). 2018. PMID: 29954951 Free PMC article. Review. - Diabetes mellitus: Cardiovascular and renal benefits of SGLT2 inhibition: insights from CANVAS.
Vallon V, Thomson SC. Vallon V, et al. Nat Rev Nephrol. 2017 Sep;13(9):517-518. doi: 10.1038/nrneph.2017.113. Epub 2017 Aug 7. Nat Rev Nephrol. 2017. PMID: 28781373 No abstract available. - Glomerular hyperfiltration: definitions, mechanisms and clinical implications.
Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW. Helal I, et al. Nat Rev Nephrol. 2012 Feb 21;8(5):293-300. doi: 10.1038/nrneph.2012.19. Nat Rev Nephrol. 2012. PMID: 22349487 Review.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical